Published in Technol Cancer Res Treat on December 01, 2005
Multimodality imaging probes: design and challenges. Chem Rev (2010) 2.61
Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol (2008) 1.59
Optical imaging-guided cancer therapy with fluorescent nanoparticles. J R Soc Interface (2009) 1.22
Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Histol (2009) 1.04
In vivo fluorescence imaging: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.95
Accurate sizing of nanoparticles using confocal correlation spectroscopy. J Phys Chem B (2006) 0.95
Targeted nanoagents for the detection of cancers. Mol Oncol (2010) 0.91
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem (2014) 0.89
Near-infrared molecular probes for in vivo imaging. Curr Protoc Cytom (2012) 0.88
Fabrication of glyconanoparticle microarrays. Anal Chem (2012) 0.87
Molecular imaging for guiding oncologic prognosis and therapy in esophageal adenocarcinoma. Hosp Pract (1995) (2011) 0.82
Applications of nanoparticles for diagnosis and therapy of cancer. Br J Radiol (2015) 0.81
Engineering of near infrared fluorescent proteinoid-poly(L-lactic acid) particles for in vivo colon cancer detection. J Nanobiotechnology (2014) 0.81
Engineering of near IR fluorescent albumin nanoparticles for in vivo detection of colon cancer. J Nanobiotechnology (2012) 0.80
Synthesis and bioevaluation of ¹²⁵I-labeled gold nanorods. Nanotechnology (2011) 0.79
Compound Cellular Imaging of Laser Scanning Confocal Microscopy by Using Gold Nanoparticles and Dyes. Sensors (Basel) (2008) 0.78
Luminescent silica nanoparticles for cancer diagnosis. Curr Med Chem (2013) 0.77
Quantitatively Understanding Cellular Uptake of Gold Nanoparticles via Radioactivity Analysis. J Nanosci Nanotechnol (2015) 0.76
Synthesis and characterization of bioactive conjugated near-infrared fluorescent proteinoid-poly(L-lactic acid) hollow nanoparticles for optical detection of colon cancer. Int J Nanomedicine (2014) 0.76
Long wavelength excitable near-infrared fluorescent nanoparticles with aggregation-induced emission characteristics for image-guided tumor resection. Chem Sci (2017) 0.75
Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci (2006) 2.05
Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal Bioanal Chem (2010) 1.88
Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension (2008) 1.37
Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. Physiol Genomics (2007) 1.35
Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. Chem Commun (Camb) (2005) 1.27
Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil (2010) 1.24
Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. Radiology (2013) 1.22
TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. Chem Commun (Camb) (2004) 1.19
Long-term skeletal muscle protection after gene transfer in a mouse model of LGMD-2D. Mol Ther (2007) 1.13
Changes in muscle T2 and tissue damage after downhill running in mdx mice. Muscle Nerve (2011) 1.13
Relative contributions of muscle activation and muscle size to plantarflexor torque during rehabilitation after immobilization. J Orthop Res (2006) 1.13
Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells. J Nanosci Nanotechnol (2005) 1.12
Penetration of living cell membranes with fortified carbon nanotube tips. Langmuir (2007) 1.12
Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors. Mol Ther (2002) 1.11
Changes in inorganic phosphate and force production in human skeletal muscle after cast immobilization. J Appl Physiol (1985) (2004) 1.10
Lower-extremity muscle cross-sectional area after incomplete spinal cord injury. Arch Phys Med Rehabil (2006) 1.06
Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping. Mol Ther (2011) 1.05
Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle. Magn Reson Med (2013) 1.05
Pluronic microemulsions as nanoreservoirs for extraction of bupivacaine from normal saline. J Am Chem Soc (2004) 1.02
Noninvasive monitoring and tracking of muscle stem cell transplants. Transplantation (2004) 0.99
Metabolic costs of isometric force generation and maintenance of human skeletal muscle. Am J Physiol Endocrinol Metab (2002) 0.99
Noninvasive monitoring of muscle damage during reloading following limb disuse. Muscle Nerve (2005) 0.97
Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy. Int J Nanomedicine (2012) 0.96
Gold-Speckled Multimodal Nanoparticles for Noninvasive Bioimaging. Chem Mater (2008) 0.95
Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am (2011) 0.93
Non-invasive analysis of myoblast transplants in rodent cardiac muscle. Int J Cardiovasc Imaging (2004) 0.93
Capillary forces between two spheres with a fixed volume liquid bridge: theory and experiment. Langmuir (2005) 0.93
A model of muscle atrophy using cast immobilization in mice. Muscle Nerve (2005) 0.91
Deficit in human muscle strength with cast immobilization: contribution of inorganic phosphate. Eur J Appl Physiol (2006) 0.90
Overexpression of insulin-like growth factor-1 attenuates skeletal muscle damage and accelerates muscle regeneration and functional recovery after disuse. Exp Physiol (2013) 0.90
Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats. Am J Physiol Endocrinol Metab (2007) 0.90
Muscle adaptations with immobilization and rehabilitation after ankle fracture. Med Sci Sports Exerc (2004) 0.89
Impact of treadmill locomotor training on skeletal muscle IGF1 and myogenic regulatory factors in spinal cord injured rats. Eur J Appl Physiol (2010) 0.88
Impact of viral-mediated IGF-I gene transfer on skeletal muscle following cast immobilization. Am J Physiol Endocrinol Metab (2010) 0.88
Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging. Small (2012) 0.86
lacZ as a genetic reporter for real-time MRI. Magn Reson Med (2010) 0.85
Fractionated photothermal antitumor therapy with multidye nanoparticles. Int J Nanomedicine (2012) 0.85
Cell death discrimination with Raman spectroscopy and support vector machines. Ann Biomed Eng (2009) 0.85
Nanoparticle characterization for cancer nanotechnology and other biological applications. Methods Mol Biol (2010) 0.85
Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. Hum Gene Ther (2011) 0.85
Regenerative responses in slow- and fast-twitch muscles following moderate contusion spinal cord injury and locomotor training. Eur J Appl Physiol (2012) 0.85
Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer. Int J Nanomedicine (2013) 0.85
Changes in muscle T2 relaxation properties following spinal cord injury and locomotor training. Eur J Appl Physiol (2006) 0.84
Adsorption density of spherical cetyltrimethylammonium bromide (CTAB) micelles at a silica/silicon surface. Appl Spectrosc (2005) 0.84
¹³C NMR metabolomics: applications at natural abundance. Anal Chem (2014) 0.84
The promise of nanotechnology for solving clinical problems in breast cancer. J Surg Oncol (2011) 0.83
An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials (2011) 0.83
Alterations in inorganic phosphate in mouse hindlimb muscles during limb disuse. NMR Biomed (2008) 0.82
What is cancer nanotechnology? Methods Mol Biol (2010) 0.82
MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy. Neuromuscul Disord (2012) 0.81
Capillary forces between surfaces with nanoscale roughness. Adv Colloid Interface Sci (2002) 0.80
Influence of Suwannee River humic acid on particle properties and toxicity of silver nanoparticles. Chemosphere (2012) 0.80
Multimodal nanoparticulate bioimaging contrast agents. Methods Mol Biol (2010) 0.79
DNA surface modified gadolinium phosphate nanoparticles as MRI contrast agents. Bioconjug Chem (2012) 0.79
Effects of muscle activation on fatigue and metabolism in human skeletal muscle. J Appl Physiol (1985) (2002) 0.79
Hindlimb muscle morphology and function in a new atrophy model combining spinal cord injury and cast immobilization. J Neurotrauma (2013) 0.78
Fluorescent and paramagnetic chitosan nanoparticles that exhibit high magnetic resonance relaxivity: synthesis, characterization and in vitro studies. J Biomed Nanotechnol (2011) 0.77
Mechanical and thermodynamic properties of surfactant aggregates at the solid-liquid interface. J Colloid Interface Sci (2004) 0.76
Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome. J Inherit Metab Dis (2015) 0.76
Tailoring silica nanotribology for CMP slurry optimization: Ca(2+) cation competition in C(12)TAB mediated lubrication. ACS Appl Mater Interfaces (2010) 0.75
Effect of the chain-length compatibility of surfactants and mechanical properties of mixed micelles on surfaces. Langmuir (2006) 0.75
Role of interaction forces in controlling the stability and polishing performance of CMP slurries. J Colloid Interface Sci (2003) 0.75
Determination of drug and fatty acid binding capacity to pluronic f127 in microemulsions. Langmuir (2007) 0.75
Effect of chain length on binding of fatty acids to Pluronics in microemulsions. Colloids Surf B Biointerfaces (2007) 0.75
The significance of electrokinetic characterization for interpreting interfacial phenomena at planar, macroscopic interfaces. Phys Chem Chem Phys (2005) 0.75
Classification of cancer cell death with spectral dimensionality reduction and generalized eigenvalues. Artif Intell Med (2011) 0.75